drugset / Trial / NCT01278498

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

NCT01278498 ↗

Phase 4 Unknown 444 enrolled Asan Medical Center Dong-A ST Co., Ltd. · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Through this study, the investigators are to demonstrate the superiority of Escitalopram over placebo for the prevention of poststroke depression in patients with acute stroke The primary hypothesis of this study is; This study will prove the superiority of Escitalopram on the prevention of poststroke depression in patients with acute stroke against placebo

Timeline

Start
2011-01
Primary completion
2014-12
Completion
2015-12

Outcome

Missed primary endpoint

paper The primary outcome did not differ by study group in the full analysis set PMID 28012485 ↗

paper Escitalopram did not significantly reduce moderate or severe depressive symptoms in patients with acute stroke. PMID 28012485 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 10 mg Oral

Indications